Eli Lilly and Company (LLY) announced, for 2018, on a non-GAAP basis, earnings per share are now expected to be in the range of $5.40 to $5.50 revised from prior guidance range of $5.10 to $5.20, reflecting company expectations of higher revenue and higher gross margin percent. On a reported basis, earnings per share for 2018 are now expected to be in the range of $3.19 to $3.29, due to higher acquired in-process research and development charges associated with the acquisition of ARMO BioSciences, partially offset by higher revenue.
from RTT - Earnings https://ift.tt/2LijAZ0
via IFTTT
No comments:
Post a Comment